These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 16005468
1. Genomic profiling of acquired resistance to apoptosis in cells derived from human atherosclerotic lesions: potential role of STATs, cyclinD1, BAD, and Bcl-XL. Gagarin D, Yang Z, Butler J, Wimmer M, Du B, Cahan P, McCaffrey TA. J Mol Cell Cardiol; 2005 Sep; 39(3):453-65. PubMed ID: 16005468 [Abstract] [Full Text] [Related]
2. Resistance to fas-induced apoptosis in cells from human atherosclerotic lesions: elevated Bcl-XL inhibits apoptosis and caspase activation. Yang Z, Gagarin D, Ramezani A, Hawley RG, McCaffrey TA. J Vasc Res; 2007 Sep; 44(6):483-94. PubMed ID: 17657164 [Abstract] [Full Text] [Related]
3. STAT5-Dependent CyclinD1 and Bcl-xL expression in Bcr-Abl-transformed cells. de Groot RP, Raaijmakers JA, Lammers JW, Koenderman L. Mol Cell Biol Res Commun; 2000 May; 3(5):299-305. PubMed ID: 10964754 [Abstract] [Full Text] [Related]
4. Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells. Pu YS, Hour TC, Chuang SE, Cheng AL, Lai MK, Kuo ML. Prostate; 2004 Jul 01; 60(2):120-9. PubMed ID: 15162378 [Abstract] [Full Text] [Related]
5. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation. Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M. Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347 [Abstract] [Full Text] [Related]
6. Cyclin D1 overexpression induces epidermal growth factor-independent resistance to apoptosis linked to BCL-2 in human A431 carcinoma. Rieber M, Rieber MS. Apoptosis; 2006 Jan 07; 11(1):121-9. PubMed ID: 16374552 [Abstract] [Full Text] [Related]
7. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo. Gao L, Zhang L, Hu J, Li F, Shao Y, Zhao D, Kalvakolanu DV, Kopecko DJ, Zhao X, Xu DQ. Clin Cancer Res; 2005 Sep 01; 11(17):6333-41. PubMed ID: 16144938 [Abstract] [Full Text] [Related]
8. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF. Huerta S, Heinzerling JH, Anguiano-Hernandez YM, Huerta-Yepez S, Lin J, Chen D, Bonavida B, Livingston EH. J Surg Res; 2007 Sep 01; 142(1):184-94. PubMed ID: 17603079 [Abstract] [Full Text] [Related]
9. Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells. Huang M, Page C, Reynolds RK, Lin J. Gynecol Oncol; 2000 Oct 01; 79(1):67-73. PubMed ID: 11006034 [Abstract] [Full Text] [Related]
10. [Relationship of Stat3 and its target gene products with malignancy in human colorectal carcinoma]. Ma XT, Wang S, Ye YJ, Du RY, Cui ZR. Ai Zheng; 2003 Nov 01; 22(11):1135-9. PubMed ID: 14613639 [Abstract] [Full Text] [Related]
11. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3. Hellsten R, Johansson M, Dahlman A, Dizeyi N, Sterner O, Bjartell A. Prostate; 2008 Feb 15; 68(3):269-80. PubMed ID: 18163422 [Abstract] [Full Text] [Related]
12. Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B. Joung YH, Lim EJ, Kim MS, Lim SD, Yoon SY, Lim YC, Yoo YB, Ye SK, Park T, Chung IM, Bae KY, Yang YM. Int J Oncol; 2008 Sep 15; 33(3):477-84. PubMed ID: 18695876 [Abstract] [Full Text] [Related]
13. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis. Chetoui N, Sylla K, Gagnon-Houde JV, Alcaide-Loridan C, Charron D, Al-Daccak R, Aoudjit F. Mol Cancer Res; 2008 Jan 15; 6(1):42-52. PubMed ID: 18234961 [Abstract] [Full Text] [Related]
14. Antisense oligonucleotide inhibition of Bcl-xL and Bid expression in liver regulates responses in a mouse model of Fas-induced fulminant hepatitis. Zhang H, Taylor J, Luther D, Johnston J, Murray S, Wyatt JR, Watt AT, Koo S, York-DeFalco C, Stecker K, Dean NM. J Pharmacol Exp Ther; 2003 Oct 15; 307(1):24-33. PubMed ID: 12893848 [Abstract] [Full Text] [Related]
15. Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events. Quintanilla-Martinez L, Kremer M, Specht K, Calzada-Wack J, Nathrath M, Schaich R, Höfler H, Fend F. Am J Pathol; 2003 May 15; 162(5):1449-61. PubMed ID: 12707028 [Abstract] [Full Text] [Related]
16. Induction of Bad-mediated apoptosis by Sindbis virus infection: involvement of pro-survival members of the Bcl-2 family. Moriishi K, Koura M, Matsuura Y. Virology; 2002 Jan 20; 292(2):258-71. PubMed ID: 11878929 [Abstract] [Full Text] [Related]
17. TIEG1 facilitates transforming growth factor-beta-mediated apoptosis in the oligodendroglial cell line OLI-neu. Bender H, Wang Z, Schuster N, Krieglstein K. J Neurosci Res; 2004 Feb 01; 75(3):344-52. PubMed ID: 14743447 [Abstract] [Full Text] [Related]
18. The anti-apoptotic molecules Bcl-xL and Bcl-w target protein phosphatase 1alpha to Bad. Ayllón V, Cayla X, García A, Fleischer A, Rebollo A. Eur J Immunol; 2002 Jul 01; 32(7):1847-55. PubMed ID: 12115603 [Abstract] [Full Text] [Related]
19. Differential expression of antiapoptotic genes in human endometrial carcinoma: bcl-XL succeeds bcl-2 function in neoplastic cells. Crescenzi E, Criniti V, Pianese M, Tecce MF, Palumbo G. Gynecol Oncol; 2000 Jun 01; 77(3):419-28. PubMed ID: 10831353 [Abstract] [Full Text] [Related]
20. Aven and Bcl-xL enhance protection against apoptosis for mammalian cells exposed to various culture conditions. Figueroa B, Chen S, Oyler GA, Hardwick JM, Betenbaugh MJ. Biotechnol Bioeng; 2004 Mar 20; 85(6):589-600. PubMed ID: 14966800 [Abstract] [Full Text] [Related] Page: [Next] [New Search]